$OGEN ORAGENICS INC Insider Trading
Get free email notifications about insider trading in ORAGENICS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
Overview of insider trading in ORAGENICS INC. Insider overview, share value development, latest insider transactions and email notifications about new events in ORAGENICS INC for free.
CIK Number: 0001174940
IRS Number: 593410522
Industry: PHARMACEUTICAL PREPARATIONS 
Trading Symbol: OGEN
Company Address: 4902 EISENHOWER BLVD SUITE 125 TAMPA 33634
Phone number: 813-286-7900
Former name: Oragen, Inc.
Oragenics, Inc. is a biopharmaceutical company, which focuses on the development of novel antibiotics and treatments against infectious disease and oral mucositis. Its technology and pipeline is comprised of antibiotics and genetically engineered bacterial strains. The company was founded by Jeffrey D. Hillman and Robert T. Zahradnik in November 1996 and is headquartered in Tampa, FL.
Market Capitalization: $38.33M
Prev close: $0.76
Average Daily Volume: 159,127
Days Low: $0.75
Year Low: $0.33
Year High: $1.20
ORAGENICS INC Latest Insider Transactions
|Date||Ticker||Company||Owner||Relationship||Transaction||Code||Cost ($)||Shares||Transaction Value ($)||Total Shares||% Holdings|
|Feb 19 2021||OGEN||ORAGENICS INC||Murphy Kimberly M||Director||Option Exercise||A||1.20||160,000||192,000||160,000|
|Feb 19 2021||OGEN||ORAGENICS INC||Sullivan Michael O'Keefe||CFO, Secretary and ...||Option Exercise||A||1.20||250,000||300,000||250,000|
|Feb 19 2021||OGEN||ORAGENICS INC||DUNTON ALAN W||Director||Option Exercise||A||1.20||160,000||192,000||160,000|
|Feb 19 2021||OGEN||ORAGENICS INC||KOSKI ROBERT C||Director||Option Exercise||A||1.20||160,000||192,000||160,000|
|Feb 19 2021||OGEN||ORAGENICS INC||KOSKI ROBERT C||Director||Gift||G||0.00||30,000||0||212,839||242.8 K to 212.8 K (-12.35 %)|
|Feb 19 2021||OGEN||ORAGENICS INC||Joslyn Alan||CEO and President||Option Exercise||A||1.20||400,000||480,000||400,000|
|Feb 19 2021||OGEN||ORAGENICS INC||POPE CHARLES L||Director||Option Exercise||A||1.20||160,000||192,000||160,000|
|Feb 19 2021||OGEN||ORAGENICS INC||Telling Fred||Director||Option Exercise||A||1.20||160,000||192,000||160,000|
|Jan 26 2021||OGEN||ORAGENICS INC||Hernandez Joseph||10% Owner||Sell||S||0.98||870,854||856,485||0||870.9 K to 0 (-100.00 %)|
|Jan 26 2021||OGEN||ORAGENICS INC||Hernandez Joseph||10% Owner||Sell||S||0.80||257,510||206,008||870,854||1.1 M to 870.9 K (-22.82 %)|
|Jan 26 2021||OGEN||ORAGENICS INC||Hernandez Joseph||10% Owner||Sell||S||0.73||629,707||460,190||1,128,364||1.8 M to 1.1 M (-35.82 %)|
|Jan 26 2021||OGEN||ORAGENICS INC||Hernandez Joseph||10% Owner||Sell||S||0.77||441,929||340,727||1,758,071||2.2 M to 1.8 M (-20.09 %)|
|Jan 26 2021||OGEN||ORAGENICS INC||Hernandez Joseph||10% Owner||Sell||S||0.84||323,997||272,157||2,200,000||2.5 M to 2.2 M (-12.84 %)|
|Jan 26 2021||OGEN||ORAGENICS INC||Hernandez Joseph||10% Owner||Sell||S||0.60||1,000,000||600,000||2,523,997||3.5 M to 2.5 M (-28.38 %)|
|Jan 26 2021||OGEN||ORAGENICS INC||Hernandez Joseph||10% Owner||Sell||S||0.58||500,000||290,200||3,523,997||4 M to 3.5 M (-12.43 %)|